234 related articles for article (PubMed ID: 21179588)
21. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
22. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cellular RNA nano-particle assembly by splicing factor SRp20.
Yoon SP; Kim HH; Kim J; Park RY; Ohn T
J Nanosci Nanotechnol; 2013 Jan; 13(1):184-7. PubMed ID: 23646715
[TBL] [Abstract][Full Text] [Related]
24. Control of the papillomavirus early-to-late switch by differentially expressed SRp20.
Jia R; Liu X; Tao M; Kruhlak M; Guo M; Meyers C; Baker CC; Zheng ZM
J Virol; 2009 Jan; 83(1):167-80. PubMed ID: 18945760
[TBL] [Abstract][Full Text] [Related]
25. Novel roles of hakai in cell proliferation and oncogenesis.
Figueroa A; Kotani H; Toda Y; Mazan-Mamczarz K; Mueller EC; Otto A; Disch L; Norman M; Ramdasi RM; Keshtgar M; Gorospe M; Fujita Y
Mol Biol Cell; 2009 Aug; 20(15):3533-42. PubMed ID: 19535458
[TBL] [Abstract][Full Text] [Related]
26. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
27. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
28. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
Jumaa H; Nielsen PJ
EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
[TBL] [Abstract][Full Text] [Related]
29. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus SM protein utilizes cellular splicing factor SRp20 to mediate alternative splicing.
Verma D; Bais S; Gaillard M; Swaminathan S
J Virol; 2010 Nov; 84(22):11781-9. PubMed ID: 20810723
[TBL] [Abstract][Full Text] [Related]
31. Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.
Wang G; Cui Y; Zhang G; Garen A; Song X
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16794-8. PubMed ID: 19805375
[TBL] [Abstract][Full Text] [Related]
32. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.
Sureban SM; Ramalingam S; Natarajan G; May R; Subramaniam D; Bishnupuri KS; Morrison AR; Dieckgraefe BK; Brackett DJ; Postier RG; Houchen CW; Anant S
Oncogene; 2008 Jul; 27(33):4544-56. PubMed ID: 18427544
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
[TBL] [Abstract][Full Text] [Related]
35. Sex-dependent up-regulation of two splicing factors, Psf and Srp20, during hippocampal memory formation.
Antunes-Martins A; Mizuno K; Irvine EE; Lepicard EM; Giese KP
Learn Mem; 2007 Oct; 14(10):693-702. PubMed ID: 17911373
[TBL] [Abstract][Full Text] [Related]
36. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
37. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
38. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
[TBL] [Abstract][Full Text] [Related]
39. Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells.
Castaño Z; Vergara-Irigaray N; Pajares MJ; Montuenga LM; Pio R
Int J Cancer; 2008 Apr; 122(7):1512-20. PubMed ID: 17973258
[TBL] [Abstract][Full Text] [Related]
40. Identification of a pre-mRNA splicing factor, arginine/serine-rich 3 (Sfrs3), and its co-expression with fibronectin in fetal and postnatal rabbit airway mucosal and skin wounds.
Li-Korotky HS; Hebda PA; Kelly LA; Lo CY; Dohar JE
Biochim Biophys Acta; 2006 Jan; 1762(1):34-45. PubMed ID: 16168628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
